申请人:Dr. Karl Thomae GmbH
公开号:US05541229A1
公开(公告)日:1996-07-30
The invention relates to benzimidazoles of the formula ##STR1## in which R.sub.1 to R.sub.2 are as defined in claim 1, 1 and 3 isomer mixtures thereof and addition salts thereof which have valuable properties. In particular, the novel compounds are angiotensin II antagonists.
该发明涉及公式##STR1##中的苯并咪唑,其中R.sub.1至R.sub.2如权利要求书中定义,1和3为其异构体混合物及其盐,具有有价值的性质。特别是,这些新化合物是血管紧张素II拮抗剂。